Background Population-level knowledge on individuals at high risk of severe and fatal
coronavirus disease 2019 (COVID-19) is urgently needed to inform targeted protection strategies …

Background Concerns over the safety of non-steroidal anti-inflammatory drug (NSAID) use
during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been …

Background the increasing number of multimorbid older people places high demands on
future health care systems. To inform the discussion on how to structure future care strategies, …

Background To facilitate research on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
a prospective cohort of all Danish residents tested for SARS-CoV-2 in Denmark is …

Background and objective Acute exacerbations in chronic obstructive pulmonary disease (COPD)
may trigger major adverse cardiac events (MACE). We aimed to determine whether …

Purpose Multi-morbidity and polypharmacy are common among older people. It is essential
to provide a better understanding of the complexity of prescription drug use among older …

Background Data on drug utilisation patterns in nursing home populations is scarce. We
aimed to describe drug use patterns in Danish nursing home residents. Methods We …

Importance During the ongoing coronavirus disease 2019 pandemic, case reports have
suggested that the use of nonsteroidal anti-inflammatory drugs (NSAIDs) may lead to adverse …

Objectives Proton pump inhibitors (PPI) are among the most frequently used drugs in the
developed countries. In recent years, their use among children and adolescents has been on …

Objective To examine the impact of ACE inhibitor (ACE-I)/angiotensin receptor blocker (ARB)
use on rate of SARS-CoV-2 infection and adverse outcomes. Methods This nationwide …